{
  "image_filename": "table_p1_mrg_det_0_017.png",
  "image_path": "FlublokPI/extracted/figures/table_p1_mrg_det_0_017.png",
  "image_type": "Table",
  "page_number": 1,
  "block_id": "mrg_det_0_017",
  "claim_id": "claim_004",
  "claim": "Vaccination with a higher-dose recombinant flu vaccine may induce a more robust antibody response than egg-based standard-dose vaccines.",
  "supports_claim": false,
  "explanation": "First page of Flublok prescribing information showing indications, dosage and administration (0.5 mL intramuscular), dosage forms and strengths, contraindications, warnings and precautions, adverse reactions, use in specific populations, and a table of contents for the full prescribing information. does not support the claim \u2014 the image contains only labeling and table of contents without any clinical or immunogenicity data comparing a higher-dose recombinant flu vaccine to egg-based standard-dose vaccines. Note: Analysis limited by the image showing only administrative and structural information; no efficacy or antibody response data are present.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "First page of Flublok prescribing information showing indications, dosage and administration (0.5 mL intramuscular), dosage forms and strengths, contraindications, warnings and precautions, adverse reactions, use in specific populations, and a table of contents for the full prescribing information.",
    "evidence_found": null,
    "reasoning": "does not support the claim \u2014 the image contains only labeling and table of contents without any clinical or immunogenicity data comparing a higher-dose recombinant flu vaccine to egg-based standard-dose vaccines.",
    "confidence_notes": "Analysis limited by the image showing only administrative and structural information; no efficacy or antibody response data are present."
  }
}